LPCN vs RL · rev $11.2M vs P/E 24, rev $8.11B
Lipocine Inc (LPCN) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
LPCN currently screens at market cap $19.3M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the LPCN and RL stock pages for the full models.
Not investment advice.